Part 1 obgyn notes Sri Lanka
    NOTES for part 1
    /
    pathology
    /
    6.Neoplasia
    /
    1.Carcinogenesis – Multistep Evolutionary Process

    1.Carcinogenesis – Multistep Evolutionary Process

    Owner
    U
    Untitled
    Verification
    Tags

    1. Core Principle – Cancer develops step-by-step

    • A single mutation is rarely sufficient.
    • Multiple cooperating genetic alterations accumulate over years/decades.
    • Analogy: combo lock – multiple digits needed.

    2. Driver vs Passenger Mutations

    Driver mutations

    • Present early – even in precursor lesions.
    • Confer selective growth advantage.
    • Initiate clonal expansion.
    • Alone are insufficient for malignancy → require cooperating mutations.

    Passenger mutations

    • Neutral mutations acquired during proliferation.
    • Do not contribute to malignant phenotype.

    3. Tumors evolve by Darwinian selection

    Mechanism:

    • Mutations occur randomly.
    • Cells with favorable mutations (growth/survival/invasion) outcompete others.
    • These successful clones expand.

    Consequences:

    1. Tumor progression → increasing aggressiveness.
    2. Declining responsiveness to therapy over time.

    4. Tumor Progression – What it means

    • Progressive accumulation of mutations.
    • Leads to:
      • uncontrolled proliferation
      • invasion
      • metastasis
      • angiogenesis
      • resistance to apoptosis
      • immune evasion

    Molecular events:

    • New mutations arise continuously.
    • Some are deleterious → kill the cell.
    • Some confer selective advantage → retained and expanded.

    5. Clonal Expansion and Heterogeneity

    • Tumors originate monoclonally from a founding cell.
    • Repeated mutation + natural selection → genetically diverse mass.
    • Diagnosed tumors = mixture of many subclonal populations.

    Memory analogy:

    “One seed → many branches.”

    6. Therapy Resistance – Why it happens

    • Pre-existing resistant subclones survive treatment.
    • Chemotherapy eliminates sensitive clones → selects for resistant ones.
    • Recurrence often contains predominantly resistant clones.

    Thus:

    • Tumor aggressiveness increases over time.
    • Responsiveness to therapy declines.

    💡 Clinical + Exam Pearls

    • Presence of a driver mutation in a benign lesion does not mean cancer—cooperating mutations must accumulate.
    • Genetic heterogeneity explains variable clinical behavior within same tumor mass.
    • Recurrent cancers typically contain cells that survived previous therapy due to resistant mutations.
    • Cancer progression mirrors natural selection: mutation → selection → clonal expansion.

    🧠 Concept Summary for Long-term Memory

    1. Multistep model
    2. cancer develops through sequential mutations

    3. Early driver mutation
    4. initiates proliferation but cannot create full malignancy alone

    5. Darwinian selection
    6. fittest clones survive and dominate

    7. Tumor progression
    8. increasing malignancy, invasion, metastasis

    9. Genetic heterogeneity
    10. monoclonal origin → polyclonal tumor at diagnosis

    11. Therapy resistance
    12. resistant subclones expand after treatment destroys sensitive clones